Article Text
PDFEconomics
Hospitalisation for more than 3 days after thrombolysis for uncomplicated myocardial infarction was not cost effective
Statistics from Altmetric.com
Footnotes
-
Sources of funding: Bayer; CIBA-Corning; Genentech; ICI Pharmaceuticals; Sanofi Pharmaceuticals.
-
For correspondence: Dr L K Newby, Duke Clinical Research Institute, PO Box 17969, Durham NC 27715-7969, USA. Fax +1 919 668 7059.
↵* The GUSTO Investigators. N Engl J Med 1993;329: 673–82.